Search results for

KPBS Midday Edition spoke with Jacob Margolis, a science reporter for LAist Public Radio and host of the podcast “The Big One: Your Survival Guide” about preparing for and responding to an earthquake.

One explanation for the rise in obesity in industrialized countries is that people burn fewer calories than people in countries where obesity is rare. A major study finds that's not the case.

The Jeffrey B. Graham Perspectives on Ocean Science Lecture Series returns to Birch Aquarium at Scripps Institution of Oceanography at UC San Diego with a three part speaker series that provides an in-depth look at the art-science collaborations that gave rise to Birch Aquarium’s "Embodied Pacific: Oceans Unseen" exhibition beginning with Superradiance. Embodying Earth. by artists Memo Akten and Katie Peyton Hofstadter. Superradiance. Embodying Earth. is a multiscreen video and sound installation by artists Memo Akten and Katie Peyton Hofstader that serves as a centerpiece of Birch Aquarium’s "Embodied Pacific: Oceans Unseen" exhibition. Inspired by conversations between the artists and Scripps researchers, this work explores the complex interactions between land, ocean and atmosphere that shape our living planet by interweaving dance, poetry, music and generative imagery with artificial intelligence. Join us for a conversation with the artists as they describe how they use art to engage us in science, evoking a visceral and intimate connection to our living planet. Seating is limited and lectures often sell out, so advanced registration is strongly recommended. Doors open at 6:30 p.m. and the lecture begins at 7 p.m. Birch Aquarium at Scripps on Facebook / Instagram / X

Yaccarino, a traditional business executive, was in many ways a strong foil to the mercurial and controversy-courting Musk. She did not cite a reason for her departure.

Mid-spring is a kaleidoscope of color: blue sage, white fiesta flower, yellow sea dahlia, red monkey flower, and purple lupine. We have previously found an impressive 52 species in just two hours – can we outdo ourselves this year? Join this nature challenge and keep your peepers peeled. Weather permitting. Wildlife is unpredictable. There is no guarantee of what you will see. Nature Collective is a local conservation and science education nonprofit organization. They work to restore habitats, provide healthier waters, and increase wildlife diversity. They are dedicated to conserving the land and providing experiences for people to fall in love with nature. Adults – Accessible Trail – Registration Required Visit: https://www.eventbrite.com/e/nature-collective-hosts-wildlife-tour-tickets-1290438218449 Nature Collective on Instagram and Facebook

Suzie Hicks the Climate Chick is an up-and-coming educator and TV host with a YouTube series tailored to kids ages 4 through 8.

Since 2022, Curebound’s signature benefit concert series has raised more than $8.5 million to support innovative cancer research. Curebound announced that legendary music artist, humanitarian, and global superstar, Elton John will headline the 2025 Concert for Cures on Friday, May 9, at Petco Park to raise awareness and funds for cutting-edge cancer research. Since its launch in 2022, Concert for Cures has raised more than $8.5 million to support early-phase adult and pediatric cancer research among Southern California’s top research institutions. Previous headliners include Alicia Keys with the San Diego Symphony Orchestra and Ed Sheeran performing to sold-out crowds at the Rady Shell at Jacobs Park. This year, Concert for Cures expands to Petco Park for an extraordinary night of music, hope, and accelerated impact in the fight against cancer. To date, Curebound has invested over $45 million in collaborative research grants. One of the top-selling solo artists of all time with more than 300 million records worldwide, Elton John has been honoured with six GRAMMYs, a Tony, two Oscars, induction into the Rock & Roll Hall of Fame and the Songwriters Hall of Fame, a Kennedy Center Honor, Legend of Live Award, and a knighthood from Her Majesty Queen Elizabeth II for “services to music and charitable services”. In January 2024, Elton John joined Hollywood’s elite group of EGOT winners after securing an EMMY Award for his historic Disney+ live concert special Elton John Live: Farewell from Dodger Stadium. Most recently, Elton and GRAMMY-winning singer-songwriter Brandi Carlile received an Academy Award nomination for Best Original Song for "Never Too Late," featured in his documentary "Elton John: Never Too Late," now streaming on Disney+. The song also appears on their upcoming collaborative studio album, "Who Believes in Angels?," set for release on April 4. “Music has the power to unite people together behind a shared cause,” says Curebound CEO Anne Marbarger. “Every person in the world has been impacted by cancer and by working together, we will accelerate better prevention, detection, and treatment options for patients and families. The funds raised at Concert for Cures will help bring us one step closer to our vision of cures in our lifetime.” Curebound corporate sponsors include: Clayco, Rady Children’s Hospital, UC San Diego, Salk Institute, Casa Dragones, ResMed, Lucier Family Foundation, Koman Family Foundation, JP Morgan Chase, UC San Diego Concierge Medicine, Schubach Aviation, Maravai Life Sciences, Ranch & Coast, Brand Napa Valley. Special thanks to the Hood Family Foundation for their generous support. Pre-sales begin March 3. Tickets go on sale at 10 a.m. on March 7 at curebound.org. For more information on Concert for Cures tickets, donations and sponsorship opportunities, please contact Mark Koczka at mark@curebound.org. About Curebound: Curebound is a philanthropic organization that raises and invests strategic funding for cancer research with the power to save lives. Through collaborative grants, corporate partnerships, and targeted investments, Curebound aims to significantly accelerate better detection, treatments, and cures for cancer. Headquartered in the major U.S. biotech hub of San Diego, amid 3,000+ life sciences companies, leading health systems, and world-class research institutions, Curebound partners with and fosters connections between these organizations to forge interdisciplinary collaborations, encourage knowledge sharing, and fund pioneering cancer research. So far, Curebound has funded $45+ million in cancer research, awarding 140+ study grants for 20+ types of pediatric and adult cancers with one vision: cures in our lifetime. Join us - www.curebound.org. Curebound on Facebook / Instagram

You might see more people wearing a neck cooling fan to fight the summer heat. But can they really help? We talk to experts about how our bodies deal with heat — and to people using the fans.

Lecture title: Decoding viruses for vaccine innovation - Front Row lecture with Andrew Ward, PhD Description: Viruses use specialized proteins to infect human cells, and understanding their structure is key to creating more effective vaccines and antiviral therapies. Scripps Research professor Andrew Ward will delve into his pioneering work on mapping these proteins with cutting-edge imaging techniques. Ward’s research provides critical insights into viral neutralization mechanisms, paving the way for advancements in vaccine development against pathogens like HIV, influenza, coronaviruses and much more. ABOUT SCRIPPS RESEARCH Scripps Research is an independent, nonprofit biomedical institute based in La Jolla, California, and ranked one of the most influential in the world for its impact on innovation. The Front Row lecture series, now in its eighth season, offers an exclusive glimpse into groundbreaking scientific discoveries in action. Reserve your seat today and learn how our scientists remain at the forefront of advancing the future of science and medicine. Join us—in the front row. Reserve your seat! Join the community in person on the Scripps Research campus or attend virtually via Zoom webinar. Scripps Research on Facebook / Instagram / X / TikTok

The idea that each year produces a few unofficial "songs of the summer" has been rattling around for ages. But do we have a strong contender this year?